4D Molecular Therapeutics, Inc. (FDMT)

USD 3.08

(0.65%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 339.89 Million 261.84 Million 353.48 Million 288.33 Million 58.23 Million 96.96 Million
Total Current Assets 296.58 Million 220.51 Million 315.42 Million 282.65 Million 52.5 Million 94.06 Million
Cash And Short Term Investments 288.23 Million 218.64 Million 315.42 Million 276.72 Million 49.65 Million 91.76 Million
Cash and Cash Equivalents 249.1 Million 218.64 Million 315.42 Million 276.72 Million 49.65 Million 91.76 Million
Short Term Investments 39.12 Million 161.2 Million 94.77 Million - - -
Net Receivables - 700 Thousand 47 Thousand 1.48 Million 978 Thousand 1.12 Million
Inventory - -5.78 Million -8.5 Million - - -
Other Current Assets 8.35 Million 6.95 Million 8.45 Million 4.44 Million 1.87 Million 1.18 Million
Total Non-Current Assets 43.3 Million 41.33 Million 38.05 Million 5.67 Million 5.72 Million 2.9 Million
Net PPE 31.66 Million 35.34 Million 28.95 Million 5.07 Million 5.04 Million 2.47 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 10.95 Million 4.9 Million 67.65 Million - - -
Tax Assets - - - - - -
Other Non Current Assets 684 Thousand 1.08 Million -58.54 Million 602 Thousand 677 Thousand 429 Thousand
Other Assets - - - - - -
Total Liabilities 32.06 Million 30.5 Million 560.48 Million 31.94 Million 131.2 Million 124.55 Million
Total Current Liabilities 18.95 Million 15.73 Million 16.33 Million 16.74 Million 12.95 Million 8.05 Million
Account Payables 3.51 Million 3.32 Million 4.76 Million 1.78 Million 1.74 Million 954 Thousand
Tax Payables - - - - - 93 Thousand
Short Term Debt 3.14 Million 2.65 Million 1.23 Million - - 93 Thousand
Deferred Revenue 273 Thousand 884 Thousand 2.59 Million 6.58 Million 5.86 Million 4.9 Million
Other Current Liabilities 12.01 Million 8.87 Million 7.74 Million 8.37 Million 5.34 Million 2.1 Million
Total Non Current Liabilities 13.11 Million 14.77 Million 18.04 Million 15.2 Million 118.24 Million 116.5 Million
Long-Term Debt 11.52 Million 13.46 Million 15.21 Million - - -
Deferred Revenue Non Current 972 Thousand 1.07 Million 2.49 Million 13.22 Million 13.6 Million 13.07 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 617 Thousand 233 Thousand 334 Thousand 1.97 Million 104.64 Million 103.42 Million
Other Liabilities - - 526.1 Million - - -
Total Equity 307.82 Million -314.49 Million -206.99 Million 256.38 Million -72.97 Million -27.58 Million
Stock Holders Equity 307.82 Million -314.49 Million -206.99 Million 256.38 Million -72.97 Million -27.58 Million
Common Stock 4000.00 3000.00 3000.00 3000.00 1000.00 1000.00
Retained Earnings -415.32 Million -314.49 Million -206.99 Million -135.67 Million -79.02 Million -30.02 Million
Accumulated other comprehensive income 16 Thousand -1.19 Million -423 Thousand -288.33 Million -102.98 Million -102.98 Million
Common Stock Equity 307.82 Million -314.49 Million -206.99 Million 256.38 Million -72.97 Million -27.58 Million
Capital Lease Obligation 11.52 Million 16.12 Million 16.44 Million - - -
Total Investments 50.07 Million 166.11 Million 162.42 Million - - -
Total Debt 14.67 Million 16.12 Million 16.44 Million - - -
Net Debt -234.43 Million -202.51 Million -298.98 Million -276.72 Million -49.65 Million -91.76 Million

Balance Sheet Charts